Frank Pallone actually said...

Generic drugs play a critical role in increasing access and reducing costs in our healthcare system.

One way to achieve this goal is to facilitate greater competition from generic and biosimilar manufacturers.

It is unacceptable and could, in fact, lead to greater illness and higher medical costs down the road.

For more than 50 years, communities and millions of individuals across the country have depended on the NFIP to help them recover from their...